Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FDAUT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,812
Award facts
- Contract value 100% obligated
- $21,812.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,812.42 delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose in 2-pen/mL formulation, with delivery completion scheduled for September 24, 2025. This non-set-aside contract represents a firm fixed-price order issued under competitive procurement procedures, with the point of performance located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support agreement extending through December 2026 that enables the contractor to supply a broad spectrum of medications and medical supplies supporting military healthcare operations globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its established federal contract portfolio. The company's demonstrated capability to fulfill military medical supply requirements through open competition is evidenced by its extensive delivery order history with the DLA Medical Supply Chain, encompassing specialty medications, brand-name and generic pharmaceuticals, vaccines, and related medical commodities across multiple therapeutic domains. This award for Cosentyx, a specialty immunosuppressant medication, exemplifies the company's role in providing pharmaceutical solutions to support military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FDAUT?
SPE2DB25FDAUT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FDAUT worth?
The government has obligated $21,812 on SPE2DB25FDAUT.
Is contract SPE2DB25FDAUT an order under another contract?
Yes. SPE2DB25FDAUT is a delivery order under SPE2DB24D1205, an indefinite delivery contract.
Was contract SPE2DB25FDAUT competed?
The extent of competition for SPE2DB25FDAUT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award